Have your own idea? Try our Stock Screener
Indian (NIFTY) Biotech Industry Analysis
UpdatedJan 31, 2025
DataAggregated Company Financials
Companies10
- 7D-10.1%
- 3M9.5%
- 1Y33.1%
- YTD-5.0%
Over the last 7 days, the Biotech industry has dropped 10%, driven by Biocon declining 6.6%. On the other hand Bharat Immunologicals & Biologicals is actually up 8.5%. This takes the industry's 12 month performance to a gain of 33%. Earnings are forecast to grow by 5.4% annually.
Industry Valuation and Performance
Has the Indian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 01 Feb 2025 | ₹658.0b | ₹162.0b | ₹11.3b | 66.4x | 58.2x | 4.1x |
| Mon, 30 Dec 2024 | ₹477.2b | ₹159.6b | ₹14.5b | 44.2x | 32.8x | 3x |
| Wed, 27 Nov 2024 | ₹479.5b | ₹159.6b | ₹14.5b | 41.1x | 33x | 3x |
| Fri, 25 Oct 2024 | ₹431.6b | ₹157.7b | ₹15.7b | 50.1x | 27.5x | 2.7x |
| Sun, 22 Sep 2024 | ₹487.1b | ₹157.7b | ₹15.7b | 35.2x | 31x | 3.1x |
| Tue, 20 Aug 2024 | ₹453.5b | ₹157.7b | ₹15.7b | 30.1x | 28.9x | 2.9x |
| Thu, 18 Jul 2024 | ₹463.7b | ₹157.4b | ₹10.4b | 50.8x | 44.8x | 2.9x |
| Sat, 15 Jun 2024 | ₹431.4b | ₹157.4b | ₹10.4b | 45.4x | 41.6x | 2.7x |
| Mon, 13 May 2024 | ₹393.0b | ₹155.5b | ₹12.0b | 46.7x | 32.8x | 2.5x |
| Wed, 10 Apr 2024 | ₹354.4b | ₹155.4b | ₹12.0b | 37.7x | 29.5x | 2.3x |
| Fri, 08 Mar 2024 | ₹356.2b | ₹155.4b | ₹12.0b | 37.3x | 29.6x | 2.3x |
| Sun, 04 Feb 2024 | ₹359.3b | ₹144.9b | ₹5.2b | 66.8x | 69x | 2.5x |
| Tue, 02 Jan 2024 | ₹336.5b | ₹145.0b | ₹5.3b | 54.8x | 64x | 2.3x |
| Thu, 30 Nov 2023 | ₹312.7b | ₹145.0b | ₹5.3b | 53.5x | 59.5x | 2.2x |
| Sat, 28 Oct 2023 | ₹295.1b | ₹133.7b | ₹4.8b | 35.5x | 62.1x | 2.2x |
| Mon, 25 Sep 2023 | ₹345.6b | ₹133.8b | ₹4.8b | 28.8x | 72.3x | 2.6x |
| Wed, 23 Aug 2023 | ₹444.4b | ₹142.3b | ₹7.2b | 36.2x | 61.9x | 3.1x |
| Fri, 21 Jul 2023 | ₹346.3b | ₹120.4b | ₹4.5b | 43.1x | 76.8x | 2.9x |
| Sun, 18 Jun 2023 | ₹319.9b | ₹120.4b | ₹4.5b | 40.6x | 70.9x | 2.7x |
| Tue, 16 May 2023 | ₹327.1b | ₹106.7b | ₹16.2b | 27.6x | 20.1x | 3.1x |
| Thu, 13 Apr 2023 | ₹297.5b | ₹106.6b | ₹16.4b | 15.8x | 18.2x | 2.8x |
| Sat, 11 Mar 2023 | ₹297.6b | ₹106.5b | ₹16.3b | 31.8x | 18.2x | 2.8x |
| Mon, 06 Feb 2023 | ₹310.5b | ₹99.2b | ₹18.0b | 29.4x | 17.3x | 3.1x |
| Wed, 04 Jan 2023 | ₹349.1b | ₹99.2b | ₹18.0b | 33.7x | 19.4x | 3.5x |
| Fri, 02 Dec 2022 | ₹374.4b | ₹99.2b | ₹18.0b | 36x | 20.9x | 3.8x |
| Sun, 30 Oct 2022 | ₹361.3b | ₹95.5b | ₹18.2b | 31.9x | 19.9x | 3.8x |
| Tue, 27 Sep 2022 | ₹365.9b | ₹95.5b | ₹18.1b | 31.2x | 20.2x | 3.8x |
| Thu, 25 Aug 2022 | ₹403.2b | ₹95.5b | ₹18.1b | 33.7x | 22.2x | 4.2x |
| Sat, 23 Jul 2022 | ₹432.4b | ₹92.1b | ₹17.7b | 31.8x | 24.5x | 4.7x |
| Mon, 20 Jun 2022 | ₹410.9b | ₹92.1b | ₹17.7b | 31.1x | 23.3x | 4.5x |
| Wed, 18 May 2022 | ₹425.4b | ₹85.4b | ₹6.9b | 54.4x | 61.4x | 5x |
| Fri, 15 Apr 2022 | ₹453.0b | ₹79.4b | ₹7.0b | 57.6x | 64.3x | 5.7x |
| Sun, 13 Mar 2022 | ₹427.9b | ₹79.4b | ₹7.0b | 54x | 60.8x | 5.4x |
| Tue, 08 Feb 2022 | ₹510.9b | ₹79.4b | ₹7.1b | 60.7x | 72.2x | 6.4x |
Price to Earnings Ratio
72.2x
Current Industry PE
- Investors are optimistic on the Indian Biotechs industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 58.2x which is higher than its 3-year average PE of 40.5x.
- The 3-year average PS ratio of 3.3x is lower than the industry's current PS ratio of 4.1x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have grown 17% per year over the last three years.
- Revenues for these companies have grown 27% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Indian Healthcare industry?
| IN Market | -1.79% | |
| Healthcare | -3.77% | |
| Biotech | -10.11% | |
| Biotech | -10.11% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 524663 Bharat Immunologicals & Biologicals | ₹27.41 | 8.5% +₹92.8m | -25.3% | PS15.5x | |
| 532041 Hindustan Bio Sciences | ₹9.49 | 6.6% +₹6.0m | 15.0% | PE67x | |
| 526139 Transgene Biotek | ₹4.60 | 0.9% +₹3.0m | -55.9% | PS152x |